NO20056060L - Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse - Google Patents

Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse

Info

Publication number
NO20056060L
NO20056060L NO20056060A NO20056060A NO20056060L NO 20056060 L NO20056060 L NO 20056060L NO 20056060 A NO20056060 A NO 20056060A NO 20056060 A NO20056060 A NO 20056060A NO 20056060 L NO20056060 L NO 20056060L
Authority
NO
Norway
Prior art keywords
polyethylene oxide
films
drug delivery
delivery systems
oxide based
Prior art date
Application number
NO20056060A
Other languages
English (en)
Inventor
Robert K Yang
Richard C Fuisz
Gary L Myers
Joseph M Fuisz
Original Assignee
Monosolrx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monosolrx Llc filed Critical Monosolrx Llc
Publication of NO20056060L publication Critical patent/NO20056060L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02—Polyalkylene oxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører de filmprodukter og fremgangsmåter for disses preparering som demonstrerer en ikke-selvaggregerende ensartet heterogenitet. Helst desintegreres filmene i vann og de kan dannes ved en kontrollert tørkeprosess, eller annen prosess som opprettholder filmens påkrevde ensartethet. Filmene inneholder en polymerkomponent, som inkluderer polyetylenoksid valgfritt blandet med hydrofile celluloseholdige polymerer. Helst inneholder filmene også et farmasøytisk og/eller kosmetisk aktivt agens med ikke mer enn et 10% avvik av det aktive farmasøytiske agens og/eller kosmetiske aktive agens pr. enhet areal av filmen.
NO20056060A 2003-05-28 2005-12-20 Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse NO20056060L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47390203P 2003-05-28 2003-05-28
PCT/US2004/017076 WO2006031209A1 (en) 2003-05-28 2004-05-28 Polyethylene oxide-based films and drug delivery systems made therefrom

Publications (1)

Publication Number Publication Date
NO20056060L true NO20056060L (no) 2006-02-07

Family

ID=35811416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056060A NO20056060L (no) 2003-05-28 2005-12-20 Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse

Country Status (8)

Country Link
EP (3) EP1663178A1 (no)
JP (1) JP4795962B2 (no)
CN (2) CN1812773B (no)
AU (2) AU2004319243B2 (no)
BR (1) BRPI0410956A (no)
CA (1) CA2544776C (no)
NO (1) NO20056060L (no)
WO (1) WO2006031209A1 (no)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2957281A1 (en) 2001-09-21 2015-12-23 Egalet Ltd. Polymer release system
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20080050422A1 (en) * 2001-10-12 2008-02-28 Monosolrx, Llc. Method of administering a film product containing a drug
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
EP2335921A1 (en) * 2004-09-30 2011-06-22 MonoSolRX, LLC Multi-layer films
WO2008028047A2 (en) * 2006-08-30 2008-03-06 Lab International Srl Bioadhesive film drug delivery system
EP2063864A4 (en) * 2006-09-20 2012-03-14 Monosol Rx Llc EDIBLE WATER-SOLUBLE FILM CONTAINING FLAVOR-REDUCING AGENT
AU2007304425B2 (en) 2006-10-02 2013-12-05 Spepharma Ag Non-mucoadhesive film dosage forms
AU2008206362A1 (en) * 2007-01-12 2008-07-24 Monosol Rx Llc High dose film compositions and methods of preparation
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
US8298583B2 (en) * 2007-10-19 2012-10-30 Monosol Rx, Llc Film delivery system for tetrahydrolipstatin
WO2010002418A2 (en) * 2008-07-01 2010-01-07 The Johns Hopkins University Quick-dissolving oral thin film for targeted delivery of therapeutic agents
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
PT2952191T (pt) 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
PL2493457T3 (pl) 2009-10-30 2018-01-31 Ix Biopharma Ltd Szybko rozpuszczalna stała postać dawkowana
JP5588688B2 (ja) 2010-01-28 2014-09-10 日東電工株式会社 フィルム状製剤
US8577488B2 (en) * 2010-02-11 2013-11-05 Monosol Rx, Llc Method and system for optimizing film production and minimizing film scrap
KR101837927B1 (ko) * 2010-03-26 2018-03-13 다우 글로벌 테크놀로지스 엘엘씨 용융-압출된 필름
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US20120107402A1 (en) * 2010-10-29 2012-05-03 Monosol Rx, Llc Process for analyzing and establishing dosage size in an ingestible film
AU2011343429B2 (en) 2010-12-16 2016-10-20 Sunovion Pharmaceuticals Inc. Sublingual films
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
EA201590165A1 (ru) 2012-07-06 2015-08-31 Эгалет Лтд. Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения
WO2014176449A1 (en) * 2013-04-25 2014-10-30 Rinsenergy LLC Oral rinse composition and method to deliver energy supplements
US10226450B2 (en) 2014-09-25 2019-03-12 Shilpa Medicare Limited Pharmaceutical film composition
US20160220480A1 (en) * 2015-02-03 2016-08-04 Intelgenx Corp. Oral dosage film exhibiting enhanced mucosal penetration
ES2819549T3 (es) * 2015-03-25 2021-04-16 Univ Der Johannes Gutenberg Univ Mainz Solución de reemplazo de sangre reológica y sus usos
CA3127926A1 (en) 2015-04-21 2016-10-27 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
KR20190005199A (ko) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11013249B2 (en) * 2016-05-13 2021-05-25 University Of Guelph Compositions for controlled release of volatile compounds
EP4371554A2 (en) 2016-12-31 2024-05-22 BioXcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US10799431B2 (en) * 2017-01-09 2020-10-13 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
US11096892B2 (en) * 2017-03-13 2021-08-24 Nano And Advanced Materials Institute Limited High loading and fast disintegration film for fast drug absorption
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
CN107325332B (zh) * 2017-07-07 2018-10-26 许辉良 速溶羟丙基甲基纤维素及其制备方法
CN114983980A (zh) 2018-06-27 2022-09-02 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
CN109382996B (zh) * 2018-12-05 2024-04-30 无锡会通轻质材料股份有限公司 一种中空epp珠粒挤出机构
KR20220005070A (ko) * 2019-05-02 2022-01-12 티어클리어 코포레이션 점안제로부터의 보존제 제거
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
CN111238199A (zh) * 2020-01-16 2020-06-05 肇庆方兴包装材料有限公司 一种解决薄膜之间粘连的生产工艺及薄膜用烘干装置
EP3895692A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Oral thin film with smooth fused film
CN111592670A (zh) * 2020-06-24 2020-08-28 上海应用技术大学 γ-聚谷氨酸分子印迹聚合物膜的制备方法
CN112472593B (zh) * 2020-11-24 2022-06-10 牡丹江医学院 一种加入甜味剂掩盖苦味的口腔溃疡药膜加工设备
CN114230840A (zh) * 2022-01-28 2022-03-25 孙琇芳 一种水溶可控型聚乙烯醇薄膜
CN114410044A (zh) * 2022-01-28 2022-04-29 孙琇芳 一种水溶型真空包装保鲜膜及其使用方法
CN114848612A (zh) * 2022-04-28 2022-08-05 青岛博益特生物材料股份有限公司 一种片状材料覆膜工艺及其生产的覆膜片状材料
CN115414876A (zh) * 2022-09-07 2022-12-02 天津科技大学 一种纤维素纳米纤丝凝胶的平板微波浓缩装置、方法和应用
CN116294531A (zh) * 2023-01-05 2023-06-23 安徽腾远化工科技有限公司 一种氨基模塑料高效烘干设备
CN116589019B (zh) * 2023-05-26 2023-10-27 深圳市一号芯环保科技有限公司 一种长效缓释型杀菌及抗氧化功能滤芯材料及制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136145A (en) 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4631837A (en) 1985-05-31 1986-12-30 Magoon Richard E Method and apparatus for drying fruit pulp and the like
AU6541786A (en) * 1985-10-09 1987-05-05 Desitin Arzneimittel Gmbh Process for producing an administration or dosage form of drugs, reagents or other active ingredients
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
DE4018247A1 (de) 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
IT1249315B (it) * 1991-05-23 1995-02-22 Euroresearch Srl Lamina di collageno non poroso per uso terapeutico, metodo ed apparecchiature per ottenerlo
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US20010006677A1 (en) * 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6153210A (en) * 1997-08-14 2000-11-28 Periodontix, Inc. Use of locally delivered metal ions for treatment of periodontal disease
US6072100A (en) * 1998-01-28 2000-06-06 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
JP2001341145A (ja) * 1999-12-23 2001-12-11 Johnson & Johnson Consumer Co Inc 水溶性フィルムの製造方法
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US20030118653A1 (en) * 2001-07-06 2003-06-26 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
WO2003030882A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform
WO2003030883A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
CN100356908C (zh) * 2003-01-30 2007-12-26 莫诺索尔克斯有限公司 具有非自聚集一致不均匀性的薄膜及由其制造的给药系统

Also Published As

Publication number Publication date
AU2010214780A1 (en) 2010-09-23
WO2006031209A1 (en) 2006-03-23
EP3210601A1 (en) 2017-08-30
CN1812773B (zh) 2012-06-27
CA2544776C (en) 2014-04-15
JP4795962B2 (ja) 2011-10-19
AU2004319243A1 (en) 2006-01-12
EP1663178A1 (en) 2006-06-07
CN1812773A (zh) 2006-08-02
AU2004319243A8 (en) 2008-08-07
CN102670568A (zh) 2012-09-19
JP2007500252A (ja) 2007-01-11
AU2004319243B2 (en) 2010-06-03
EP2716284A2 (en) 2014-04-09
CA2544776A1 (en) 2006-03-23
EP2716284A3 (en) 2014-11-05
BRPI0410956A (pt) 2006-07-04

Similar Documents

Publication Publication Date Title
NO20056060L (no) Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse
WO2008100375A3 (en) Polymer-based films and drug delivery systems made therefrom
ES2486848T3 (es) Producto de confitería
Agrawal et al. Novel drug release profiles from micellar solutions of PLA–PEO–PLA triblock copolymers
Ruel-Gariepy et al. In situ-forming hydrogels—review of temperature-sensitive systems
Fan et al. Thermosensitive hydrogels and advances in their application in disease therapy
Hsu et al. Multimonth controlled small molecule release from biodegradable thin films
Maver et al. Polysaccharide thin solid films for analgesic drug delivery and growth of human skin cells
AU1387002A (en) New cross-linked derivatives of hyaluronic acid
US8691278B2 (en) Self solidifying bioerodible barrier implant
Garipova et al. Mucoadhesive interpolyelectrolyte complexes for the buccal delivery of clobetasol
Maksym‐Bębenek et al. Study on Self‐Assembled Well‐Defined PEG Graft Copolymers as Efficient Drug‐Loaded Nanoparticles for Anti‐Inflammatory Therapy
WO2006073430A3 (en) Therapeutic delivery system comprising a high molecular weight peg-like compound
Shin et al. Effect of polyethylene glycol molecular weight on cell growth behavior of polyvinyl alcohol/carboxymethyl cellulose/polyethylene glycol hydrogel
Ning et al. On-demand prolongation of peripheral nerve blockade through bupivacaine-loaded hydrogels with suitable residence periods
Martin et al. Oxidation‐responsive, tunable growth factor delivery from polyelectrolyte‐coated implants
Gunbas et al. Semi-IPN chitosan/PEG microspheres and films for biomedical applications: characterization and sustained release optimization
Dadou et al. Elucidation of the controlled-release behavior of metoprolol succinate from directly compressed xanthan gum/chitosan polymers: Computational and experimental studies
Gajra et al. Mucoadhesive hydrogel films of econazole nitrate: formulation and optimization using factorial design
Riccio et al. Chitosan/nanocellulose‐based bionanocomposite films for controlled betamethasone and silver sulfadiazine delivery
Shibata et al. Thermoresponsive gelation of amphiphilic random copolymer micelles in water
Ballance et al. Stretchable, anti-bacterial hydrogel activated by large mechanical deformation
Roig‐Roig et al. Preparation, characterization, and release properties of hydrogels based on hyaluronan for pharmaceutical and biomedical use
Le et al. Sulfonamide functionalized amino acid‐based pH‐and temperature‐sensitive biodegradable injectable hydrogels: Synthesis, physicochemical characterization and in vivo degradation kinetics
Krtouš et al. Thin films of cross-linked polylactic acid as tailored platforms for controlled drug release

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: AQUESTIVE THERAPEUTICS INC., US

FC2A Withdrawal, rejection or dismissal of laid open patent application